Contribution of T cells to the development of autoimmune diabetes in the NOD mouse model

BioEssays

Volumn 20, Issue 9, 1998, Pages 750-757

  Toyoda, Hiroo ^a,c   Formby, Bent ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b SANSUM DIABETES RESEARCH INSTITUTE   (United States)

^c CEDARS SINAI MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMALIA;

EID: 0032170273     PISSN: 02659247     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1521-1878(199809)20:9<750::AID-BIES8>3.0.CO;2-K     Document Type: Review

References (66)

1. Kikutani H, Makino S (1992) The murine autoimmune diabetes model: NOD and related strains. Adv Immunol 51:285-322.
2. Birk O, Cohen IR (1993) T-cell autoimmunity in type I diabetes mellitus. Curr Opin Immunol 5:903-909.
3. Rotter JI, Vadheim CM, Rimoin DL (1992) In King RA, Rotter JI, Motulsky AG (eds): Diabetes Mellitus (chapter) in the Genetic Basis of Common Diseases. Oxford Monographs on Medical Genetics. No. 20. New York: Oxford University Press, pp 413-481.
4. Thomson G (1995) HLA disease associations: Model for the study of complex human genetic disorders. Crit Rev Clin Lab Sci 32:183-219.
5. Wicker LS, Todd JA, Peterson LB (1995) Genetic control of autoimmune diabetes in the NOD mouse. Annu Rev Immunol 13:179-200
6. Vyse TJ, Todd JA (1996) Genetic analysis of autoimmune diseases. Cell 85:311-313.
7. Mosmann TR, Coffman RL (1989) TH1 and TH2 cells: Different patterns of lymphokine secretion lead to different functional properties. Annu Rev Immunol 7:145-173.
8. Fitch FW, McKisic MD, Lancki DW, Gajewski TF (1993) Differential regulation of murine lymphokine subsets. Annu Rev Immunol 11:29-48.
9. Romagnani S (1994) Lymphokine production by human T cells in disease states. Annu Rev Immunol 12:227-257.
10. Charlton B, Lafferty KJ (1995) The Th1/Th2 balance in autoimmunity. Curr Opin Immunol 7:793-798
11. Nicholson LB, Kuchroo VK (1996) Manipulation of the Th1/h2 balance in autoimmune disease. Curr Opin Immunol 8:837-842.
12. Mosmann TR, Sad S (1996) The expanding universe of T-cell subsets: Th1, Th2 and more. Immunol Today 17:138-146.
13. Mosmann TR, Li L, Sad S (1997) Functions of CD8 T-cell subsets secreting different cytokine patterns. Semin Immunol 9:87-92.
14. Makino S, Kunimoto K, Muraoka Y, Mizushima Y, Katagiri K, Tochino Y (1980) Breeding of a non-obese diabetic strain of mice. Exp Anim 29:1-13.
15. Riley WJ, Maclaren NK, Lezotte DC, Spillar RP, Rosenbloom AL (1981) Thyroid autoimmunity in insulin-dependent diabetes mellitus: The case for routine screening. J Pediatr 98:310-354.
16. Lorini R, d'Annunzio G, Vitali L, Scaramuzza A (1996) IDDM and autoimmune thyroid disease in the pediatric age group. J Pediatr Endocrinol Metab 9:89-94.
17. Wu C, Warrier RR, Wang X, Presky DH, Gately MK (1997) Regulation of interleukin-12 receptor beta 1 chain expression and interleukin-12 binding by human peripheral blood mononuclear cells. Eur J Immunol 27:147-154.
18. Li-Weber M, Salgame P, Hu C, Davydov IV, Krammer PH (1997) Differential interaction of nuclear factors with the PRE-1 enhancer element of the human IL-4 promoter in different T cell subsets. J Immunol 158:1194-1200.
19. Manetti R, Paronchi P, Giudizi MG, Piccinni MP, Maggi E, Trinchieri G, Romagnani S (1993) Natural killer cell stimulatory factor (interleukin 12 (IL-12)) induces T helper type 1 (Th1)-specific immune responses and inhibits the development of IL-4-producing Th cells. J Exp Med 177:1199-1204.
20. Manetti R, Gerosa F, Giudizi MG, Biagiotti R, Parronchi P, Piccinni MP, Sampognaro S, Maggi E, Romagnani S, Trinchieri G, et al. (1994) Interleukin 12 induces stable priming for Interferon gamma (IFN-gamma) production during differentiation of human T helper (Th) cells and transient IFN-gamma production in established Th2 cell clones. J Exp Med 179:1273-1283.
21. Bergman B, Haskins K (1997) Autoreactive T-cell clones from the nonobese diabetic mouse. Proc Soc Exp Biol Med 214:41-48.
22. + T-cells from diabetic versus pre-diabetic NOD.NON-Thy-1a donors. Diabetes 42:44-54.
23. Rohane PW, Shimada A, Kim DT, Edwards CT, Charlton B, Shultz LD, Fathman CG (1995) Islet-infiltrating lymphocytes from prediabetic NOD mice rapidly transfer diabetes to NOD-scid/scid mice. Diabetes 44:550-554.
24. Peterson JD, Haskins K (1996) Transfer of diabetes in the NOD-scid mouse by CD4 T-cell clones: Differential requirement for CD8 T-cells Diabetes 45:328-336.
25. Boitard C, Yasunami R, Dardenne M, Bach J-F (1989) T cell-mediated inhibition of the transfer of autoimmune diabetes in NOD mice. J Exp Med 169:1669-1680.
26. + β islet cell-reactive T cell clones that suppress autoimmune diabetes in nonobese diabetic mice. J Exp Med 182:87-97.
27. + suppressor T cell completely prevents spontaneous autoimmune diabetes and recurrent diabetes in syngeneic islet-transplant NOD mice. J Autoimmun 9:331-339.
28. + T cells in the initiation of insulin-dependent diabetes mellitus. Eur J Immunol 26:1762-1769.
29. Mueller R, Sarvetnick N (1995) Transgenic/knockout mice - tools to study autoimmunity. Curr Opin Immunol 7:799-803.
30. Kägi D, Odermatt B, Ohashi PS, Zinkernagel RM, Hengartner H (1996) Development of insulitis without diabetes intransgenic mice lacking perforin-dependent cytotoxicity. J Exp Med 183:2143-2152.
31. + T cell-mediated spontaneous diabetes in neonatal mice. J Immunol 157:978-983.
32. Wong S, Visintin I, Wen L, Flavell RA, Janeway CA (1996) CD8 T cell clones from young nonobese diabetic (NOD) islets can transfer rapid onset of diabetes in NOD mice in the absence of CD4 cells. J Exp Med 183:67-76.
33. Feldman M, Brennan FM, Maini RN (1996) Role of cytokines in rheumatoid arthritis. Annu Rev Immunol 14:397-440.
34. Rabinovitch A, Suarez-Pinzon WL, Sorensen O, Bleackley RC, Power RF (1995) IFN-gamma expression in pancreatic islet-infiltrating mononuclear cells correlates with autoimmune diabetes in nonobese diabetic mice. J Immunol 154:4874-4882
35. Trembleau S, Penna G, Bosi E, Mortara A, Gately MK, Adorini L (1995) Interleukin 12 administration induces T helper type 1 cells and accelerate autoimmune diabetes in NOD mice. J Exp Med 181:817-821.
36. Toyoda H, Formby B, Magalong D, Redford A, Chan E, Takaei S, Charles MA (1994) In situ cytokine gene expression during development of type I diabetes in the non-obese diabetic mouse. Immunol Lett 39:283-288.
37. Pennline K, Roque-Gaffney E, Monahan M (1994) Recombinant human IL-10 (rhulL-10) prevents the onset of diabetes in the nonobese diabetic (NOD) mouse. Clin Immunol Immunopathol 71:169-175.
38. Rapoport MJ, Jaramillo A, Serreze DV, Leiter EH, Cyopick P, Danska JS, Delovitch TL (1993) Interleukin-4 reverses T cell proliferative unresponsiveness and prevents the onset of diabetes in nonobese diabetic mice. J Exp Med 178:87-99.
39. Mueller R Krahl T, Sarvetnick N (1996) Pancreatic expression of lnterleukin-4 abrogates insulitis and autoimmune diabetes in nonobese diabetic (NOD) mice. J Exp Med. 184:1093-1099.
40. Satoh J, Seino H, Abo T, Tanaka SI, Shintani S, Ohta S, Tamura K, Sawai T, Nobunaga T, Oteki K, Kumagai K, Toyota T (1989) Recombinant human tumor necrosis factor a suppresses autoimmune diabetes in nonobese diabetic mice. J Clin Invest 84:1345-1348.
41. Yang X-D, Tisch R, Singer S, Cao Z, Liblau R, Schreiber R, McDevitt HO (1994) Effect of tumor necrosis factor α on insulin-dependent diabetes mellitus in NOD mice. I. The early development of autoimmunity and the diabetogenic process. J Exp Med 180:995-1004.
42. Grewal IS, Grewal KD, Wong ES, Picarella DE, Janeway CA, Flavell RA (1996) Local expression of transgenic encoded TNFα in islets prevents autoimmune diabetes in nonobese diabetic (NOD) mice by preventing the development of auto-reactive islet-specific T cell. J Exp Med 184:1963-1974.
43. Sarvetnick N, Shizuru J, Liggitt D, Martin L, McIntyre B, Gregory A, Parslov T, Stewart T (1990) Loss of pancreatic islet tolerance induced by β-cell expression of interferon-γ. Nature 346:844-847.
44. Hultgren B, Huang X, Dybdal N, Stewart TA (1996) Genetic absence of gamma-interferon delays but does not prevent diabetes in NOD mice. Diabetes 45:812-817.
45. McFarland HF (1996) Complexities in the treatment of autoimmune disease. Science 274:2037-2038.
46. Katz JD, Benoist C, Mathis D (1995) T helper subsets in insulin-dependent diabetes. Science 268:1185-1188.
47. Wogensen L, Lee M-S, Sarvetnick N (1994) Production of interleukin 10 by islet accelerates immune-mediated destruction of β cells in nonobese diabetic mice. J Exp Med 179:1379-1384.
48. Moritani M, Yoshimoto K, Tashiro F, Hashimoto C, Miyazaki J, Ii S, Kubo E, Iwahara H, Hayashi Y, Sano T, Itakura M (1994) Transgenic expression of IL-10 in pancreatic islet beta cells accelerates autoimmune insulitis and diabetes in non-obese diabetic mice. Int Immunol 6:1927-1936.
49. Lee MS, Mueller R, Wicker LS, Peterson LB, Sarvetnick N (1996) IL-10 is necessary and sufficient for autoimmune diabetes in conjunction with NOD MHC homozygosity. J Exp Med 183:2663-2668.
50. Ansar Ahmed S, Penhale WJ, Talal N (1985) Sex hormones, immune responses, and autoimmune diseases. Am J Pathol 121:531-551.
51. Homo-Delarche F, Fitzpatrick F, Christeff N, Nunez EA, Bach JF, Dardenne M (1991) Sex steroids, glucocorticoids, stress and autoimmunity. J Steroid Biochem Mol Biol 40:619-637.
52. Wilder RL (1995) Neuroendocrine-immune system interactions and autoimmunity. Annu Rev Immunol 13:307-338.
53. Cutolo M, Sulli A, Barone A, Seriolo B, Accardo S (1996) Sex hormones, proto-oncogene expression and apoptosis: Their effects on rheumatoid synovial tissue. Clin Exp Rheumatol 14:87-94.
54. Chen HM, Jovanovic-Peterson L, Desai T, Peterson CM. (1996) Lessons learned from the non-obese diabetic mouse. II. Amelioration of pancreatic autoimmune isograft rejection during pregnancy. Am J Perinatol 13:249-254.
55. Piccinni MP, Giudizi MG, Biagiotti R, Beloni L, Giannarini L, Sampognaro S, Parronchi P, Manetti R, Annuziato F, Livi C, Romagnani S, Maggi E (1995) Progesterone favors the development of human T helper cells producing Th2 type cytokines and promote both IL-4 production and membrane CD30 expression in established Th1 cell clones. J Immunol 155:128-133.
56. Fox HS (1992) Androgen treatment prevents diabetes in nonobese diabetic mice. J Exp Med 175:1409-1412.
57. Hawkins T, Gala RR, Dunber JC (1993) The effect of neonatal sex hormone manipulation on the incidence of diabetes in nonobese diabetic mice. Proc Soc Exp Biol Med 202:201-205.
58. Toyoda H, Takei S, Formby B (1996) Effect of 5-α dihydrotestosterone on T-cell proliferation of the female nonobese diabetic mouse. Proc Soc Exp Biol Med 213:287-293.
59. Fox HS, Bond BL, Parslow TG (1991) Estrogen regulates the IFN-γ promoter. J immunol 146:4362-4367.
60. Dalal M, Kim S, Voskuhl RR (1997) Testosterone therapy ameliorates experimental autoimmune encephalomyelitis and induces a T helper 2 bias in the autoantigen-specific T lymphocytes response. J Immunol 159:3-6.
61. Morahan G, Huang D, Tait BD, Colman PG, Harrison LC (1996) Markers on distal chromosome 2q linked to insulin-dependent diabetes mellitus. Science 272:1811-1813.
62. Eisenbarth GS (1986) Type I diabetes mellitus: a chronic autoimmune diabetes N Engl J Med 314:1360-1368.
63. Shimada A, Charlton B, Taylor-Edwards C, Fathman CG (1996) β-cell destruction may be a late consequence of the autoimmune process in nonobese diabetic mice. Diabetes 45:1063-1067.
64. Garchon HJ, Luan J-J, Eloy L Bédossa P, Bach JF (1994) Genetic analysis of immune dysfunction in nonobese diabetic (NOD) mice: Mapping of a susceptibility locus to the bcl-2 gene correlates with increased resistance of NOD T cell to apoptosis induction. Eur J Immunol 24:380-384.
65. Kurrer MO, Pakala SV, Hanson HI, Katz JD (1997) β cell apoptosis in T cell-mediated autoimmune diabetes. Proc Natl Acad Sci USA 94:213-218.
66. Benoist C, Mathis D (1996) Cell death mediators in autoimmune diabetes - No shortage of suspects. Cell 89:1-3.